Position in NVAX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$986,142
+$82,969 QoQ
Shares Held
104,686
-5.7% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#63
of 263 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. NVAX ranks #65 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,398 | $11,622,488 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,444 | $6,512,251 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,814 | $4,158,428 | |
| 4 | MRNA |
Moderna, Inc.
|
33,142 | $2,320,934 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
17,163 | $2,278,044 | |
| 6 | CYTK |
Cytokinetics Inc
|
25,572 | $2,178,478 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
5,770 | $2,144,535 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
18,455 | $2,116,234 |
All Filings in NVAX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $986,142 | 104,686 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $903,173 | 110,955 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $817,776 | 121,693 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $486,057 | 56,062 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $335,745 | 53,293 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $370,728 | 57,836 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $556,472 | 69,213 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $934,215 | 73,968 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $624,302 | 49,313 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,228,737 | 257,058 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,231,924 | 256,651 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,193,108 | 164,794 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,479,929 | 199,183 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,314,212 | 189,641 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $459,167 | 8,928 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $693,709 | 9,419 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,487,355 | 10,396 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,503,890 | 12,078 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,470,014 | 11,634 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,511,868 | 13,854 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,477,172 | 13,247 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,254,259 | 11,576 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||